Novel prognostic prediction models for patients with stage IV colorectal cancer after concurrent curative resection
Norikatsu Miyoshi(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Masayuki Ohue(Hyogo Medical University), Hirofumi Akita(The University of Osaka), Jiro Okami(Osaka Medical Center for Cancer and Cardiovascular Diseases), Hidenori Takahashi(Osaka International Cancer Institute), Yasuhiro Fujiwara(Yokohama City University), Masahiko Higashiyama(Osaka City General Hospital), Keijiro Sugimura(Osaka International Cancer Institute), Masayoshi Yasui(Osaka International Cancer Institute), Kunihito Gotoh(Osaka International Cancer Institute), Tatsushi Shingai(Kinki Central Hospital), S. Noura(Osaka Medical Center for Cancer and Cardiovascular Diseases), Shigeru Marubashi(Osaka International Cancer Institute)
Cited by 23
Related Papers
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
An antitumor promoter from Moringa oleifera Lam.
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|1999|404